Alzamend Neuro Current Ratio Growth & History (ALZN)

Alzamend Neuro's current ratio was 1.31 for fiscal 2026.

View full Alzamend Neuro company overview

Alzamend Neuro annual current ratio history

Alzamend Neuro annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20262026-04-301.31−5.27−80.08%
20252025-04-306.586.44+4563.21%
20242024-04-300.14−1.89−93.06%
20232023-04-302.03−10.34−83.57%
20222022-04-3012.379.14+282.17%
20212021-04-303.241.41+77.10%
20202020-04-301.83

Alzamend Neuro current ratio trends

Over the last five fiscal years, Alzamend Neuro's current ratio decreased from 3.24 to 1.31, a change of −1.93. The latest reported quarter, Q4 2026, shows 1.31.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Alzamend Neuro source filings ↗

Community posts

It’s quiet here.

No posts about ALZN yet. Start the conversation.

Write the first post